Core D: Next-Gen Sequencing and Bioinformatics
- Institution
- COLD SPRING HARBOR LABORATORY, NY
- Principal investigator
- William Richard Mccombie
- Funding
- $265K
- Duration
- 1997–2028
Moonbase score
Still being scored
Abstract
CORE D - NEXT-GEN SEQUENCING AND BIOINFORMATICS PROJECT SUMMARY Core D offers world-class genomics and bioinformatics services to the members of the Program. The Next Generation sequencing facility was strongly supported by CSHL during the last five years, and it has extended its capability in short (Illumina HiSeq2500, MiSeq and NextSeq) and long read technologies (Pacific Biosciences, Oxford Nanopore). Core D offers an extensive array of sequencing applications, including but not limited to RNA- Seq, Iso-Seq, whole genome sequencing, targeted sequencing (exomes, gene set, and amplicons), ChIP-Seq, ChIRP-seq, and single-cell sequencing. Core D will also provide a wide array of bioinformatic services, which includes the continued development of novel adaptations of STAR for defining the transcriptome of cancer cells. A key focus of these innovations will be to map splicing patterns for investigation of ASO-mediated perturbations. The Core will continue working with members to develop new sequencing and computational applications, including in the area of long sequencing reads and single-cell sequencing, The Core will also offer experimental design support, sequencing project management and sequencing QC analysis to the investigators.
LOADING MOONBASE SCORE
Questions for COLD SPRING HARBOR LABORATORY
Answered by the team behind this research.
No questions yet. Sign in to ask the first one
Related grants
Same researchers, same institution, same topic, scored first.
- NIH · Cold Spring Harbor LaboratoryNot yet scored
Sequencing Technologies & Analysis Shared Resource
William Richard Mccombie · $273K · 1997–2026
- NIH · Cold Spring Harbor LaboratoryReviewed
CSHL Statistical Methods for Functional Genomics Course
Charla A Lambert · $92K · 2021–2026
- NIH · Cold Spring Harbor LaboratoryNot yet scored
Proximity-triggered, mutant-specific modification of K-Ras(G12C) with local polypharmaceutical release
John Edward Moses · $269K · 2025–2027